NIV

C.K. McWhorter Grants New York City Ballet with McWhorter Family Trust Warrant of Excellence, Recognizing Artistic Innovation and Cultural Leadership

Retrieved on: 
Wednesday, April 10, 2024
Creativity, NIV, NYCB, Entertainment

NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- The McWhorter Family Trust, committed to supporting excellence in the arts and fostering cultural enrichment, proudly announces the awarding of the esteemed McWhorter Family Warrant of Excellence to New York City Ballet (NYCB).

Key Points: 
  • NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- The McWhorter Family Trust, committed to supporting excellence in the arts and fostering cultural enrichment, proudly announces the awarding of the esteemed McWhorter Family Warrant of Excellence to New York City Ballet (NYCB).
  • As a symbol of distinction and honor, the McWhorter Family Trust Warrant of Excellence is bestowed upon NYCB in recognition of the company's unwavering dedication to artistic innovation, creativity, and cultural leadership.
  • "New York City Ballet, a beacon of artistic excellence and cultural leadership," said Carter Kennedy McWhorter - (C.K.
  • The McWhorter Family Trust Warrant of Excellence serves as a testament to the appreciation McWhorter Family Trust has for New York City Ballet, reflecting a shared commitment to advancing the arts and fostering cultural enrichment for all.

KIKI World Announces $7M Funding Round Led by a16z crypto and The Estée Lauder Companies' NIV

Retrieved on: 
Tuesday, April 9, 2024
Crypto, Entrepreneurship, ELC, General partnership, Beauty, Brand.com, Social media, Internet, KIKI, Senior, NFC, Andreessen Horowitz, Heart, Creativity, API, NIV, Cryptocurrency

The investment from a16z crypto follows KIKI's participation in its spring 2023 Crypto Startup Accelerator program.

Key Points: 
  • The investment from a16z crypto follows KIKI's participation in its spring 2023 Crypto Startup Accelerator program.
  • NIV invested in November 2022 at KIKI's concept stages prior to launch.
  • KIKI World's initial launch featured connected beauty products co-created by the KIKI World community.
  • "Consumers are at the heart of what we do at The Estée Lauder Companies," says Shana Randhava, Senior Vice President, NIV, The Estée Lauder Companies (ELC).

Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE

Retrieved on: 
Friday, March 15, 2024
Hypercapnia, Respironics, VAPO, Business, Patient, Mechanical ventilation, Spirometry, Business development, Quality of life, Respiratory disease, OTCQX, NIV, COPD, FDA, HME, Hospital

EXETER, N.H., March 15, 2024 /PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Solution at the upcoming MEDTRADE conference.

Key Points: 
  • EXETER, N.H., March 15, 2024 /PRNewswire/ -- Vapotherm, Inc., (OTCQX: VAPO), ("Vapotherm" or the "Company") today announced the debut of its Access365™ Home Ventilation Solution at the upcoming MEDTRADE conference.
  • Dr. Jessica Whittle, Chief Medical Officer of Vapotherm, emphasized the company's commitment to improving the lives of hypercapnic patients in the home.
  • "(1)
    The highly anticipated Access365 home ventilator will be unveiled at MEDTRADE Dallas on March 27th.
  • Joe Army, President and CEO of Vapotherm, underscored the significance of the solution, stating, "Vapotherm is committed to supporting patients both in and out of the hospital.

Respiratory Disease Testing Market Size & Trends Analysis 2023 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 28, 2023
Health, General Health, COPD, Prevalence, Medtronic, BD (company), Application, Respiratory disease, Patient, Occupational lung disease, Airway management, USD, Chronic obstructive pulmonary disease, CareFusion, CT scan, Diagnosis, Growth, Respironics, Asthma, NIV, Medical device, Pharmaceutical industry, Medical imaging

The "Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030
    The market is driven by the rising prevalence of respiratory diseases.
  • Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.
  • These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market

BMC Celebrates World COPD Day 2023 With Innovative Products and Global Events

Retrieved on: 
Wednesday, November 15, 2023
World Health Organization, Sleep, COPD, BMC, Ventilation, Depression, Static pressure, Research, Urinary tract infection, Air pollution, WHO, Lung, Disease, Risk, Threshold limit value, Life, Patient, Chronic pain, Lung cancer, NIV, Diagnosis, Death, Wheeze, Oxygen, Chronic obstructive pulmonary disease, Quality of life, Periodic breathing, Knowledge, Inflammation, Smoking, Personal protective equipment, Medical device

BEIJING, Nov. 15, 2023 /PRNewswire/ -- World COPD Day is a global campaign that aims to raise awareness of chronic obstructive pulmonary disease (COPD) and improve the quality of life for people living with this condition1.

Key Points: 
  • BEIJING, Nov. 15, 2023 /PRNewswire/ -- World COPD Day is a global campaign that aims to raise awareness of chronic obstructive pulmonary disease (COPD) and improve the quality of life for people living with this condition1.
  • Research findings indicate that COPD will become the world's third leading cause of death and affects more than 250 million people worldwide.2
    The theme for this year's World COPD Day, which falls on November 15, 2023, is "Breathing is Life - Act Earlier".
  • These products can help improve the oxygenation, ventilation, and inflammation of the lungs, and reduce the symptoms and exacerbations of COPD.
  • People join the World COPD Day campaign by sharing the stories, experiences and tips on how to keep the lungs healthy and cope with COPD to help more people who suffering from COPD.

The Estée Lauder Companies and NYKAA Announce Winners of the Second Edition of BEAUTY&YOU India

Retrieved on: 
Monday, November 6, 2023
Biotechnology, Cosmetics, Retail, Health, Entertainment, Vitamins, Supplements, Online Retail, Luxury, Film & Motion Pictures, Other Science, Research, Specialty, Science, Fashion, Rhea, Palm oil, Perfume, ESG, Skin care, Breakthrough, Skin, Entrepreneurship, Anaita Shroff Adajania, Multimedia, Senior, Sohrai, City, About You Awards, Biology, Marketing, Partnership, HOUSE, Hariprasad Chaurasia, Food security, ELC, Community, Creative, Safety, Biorefinery, NIV, Philosophy, Memory, Climate change, Management, Film industry, Beauty, Interco, DECIEM

The Estée Lauder Companies (ELC) and NYKAA, one of India’s leading omnichannel beauty and lifestyle retailers, announce the winners of the 2023 BEAUTY&YOU Awards in India.

Key Points: 
  • The Estée Lauder Companies (ELC) and NYKAA, one of India’s leading omnichannel beauty and lifestyle retailers, announce the winners of the 2023 BEAUTY&YOU Awards in India.
  • The winners, listed below, were announced at an awards evening at Snowball Studios, Mumbai, on November 2, 2023.
  • Winners for the Community category were determined via an independent voting process on www.beautyandyouawards.com and an analysis of social engagement.
  • Among other resources, BEAUTY&YOU India will provide winners with financial support, continued mentorship, increased awareness, and distribution support.

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024

Retrieved on: 
Thursday, October 26, 2023
Astral, ERS, Airview Historic District, Australian Securities Exchange, CDI, NYSE, CHESS, ASV, OSA, Physician, Congress, Acquisition, DAN, Webcast, Sleep, European Respiratory Society, NIV, ResMed, Software as a service, Cryptocurrency, Health care, Video game, Pharmaceutical industry, CPAP

SAN DIEGO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2023.

Key Points: 
  • Revenue grew by 15 percent on a constant currency basis, driven by increased demand for our sleep and respiratory care devices.
  • Revenue in Europe, Asia, and other markets, excluding Software-as-a-Service, grew by 18 percent on a constant currency basis.
  • SG&A expenses improved to 20.2 percent of revenue in the quarter, compared with 20.4 percent in the same period of the prior year.
  • ResMed will discuss its first-quarter fiscal year 2024 results on its webcast at 1:30 p.m. U.S. Pacific Time today.

FDA Clears ReddyPort® Non-Invasive Ventilation Device

Retrieved on: 
Tuesday, July 18, 2023
NIV, COPD, Elbow, Joint Commission, Failure, Failure mode and effects analysis, Xerostomia, Patient, Mask, Risk, ICU, Lung compliance, Yankauer suction tip, Mouth, Caregiver, Dentistry

"ReddyPort's patented elbow is central to the eco-system we are building to help mitigate clinical obstacles tied to NIV therapy from dry-mouth, oral biofilm accumulation to speech recognition," says Tony Lair, ReddyPort CEO.

Key Points: 
  • "ReddyPort's patented elbow is central to the eco-system we are building to help mitigate clinical obstacles tied to NIV therapy from dry-mouth, oral biofilm accumulation to speech recognition," says Tony Lair, ReddyPort CEO.
  • ReddyPort's elbow features a self-sealing valve that provides seamless oral access to the patient's mouth without the need for mask removal, alleviating the risk of therapeutic pressure loss and maintaining lung compliance.
  • The ReddyPort microphone amplifies audible speech tones while minimizing background noise, helping patients to regain their ability to effectively communicate with caregivers and family members.
  • The ReddyPort System, with the ReddyPort elbow at its core, promotes NIV success by empowering clinicians with efficient access to provide oral care without removing the mask or loss of therapeutic pressures.

ether.fi Completes USD 5.3 Million Funding Round Co-led by NIV and Chapter One, Launches Liquid Staking Platform

Retrieved on: 
Wednesday, March 1, 2023
DSRV, Decentralized finance, USS Thomaston (LSD-28), Ecosystem, Chapter One, Maelstrom, ETH, NIV, Risk, Web3, NFT, Capital, DVT, Distribution, LSD, Version One Ventures, Treasury, Virtus Investment Partners, Kiln, Cryptocurrency, Ethereum

LONDON, March 1, 2023 /PRNewswire/ -- ether.fi, a liquid staking protocol designed with decentralization at its core, announced today that it has completed a USD$5.3m funding round co-led by investors North Island Ventures (NIV,) Chapter One, and Node Capital, with participation from Arrington Capital, Maelstrom, Version One Ventures and Purpose Investments.

Key Points: 
  • Node Capital, Arrington Capital, Maelstrom, Version One Ventures, and Purpose Investments also back staking protocol to address issues of centralized staking markets.
  • As a decentralized non-custodial staking solution, ether.fi allows stakers to retain control of their keys while delegating validator operations to a node operator.
  • ether.fi brings a new platform approach to the staking market.
  • Ethereum stakers depositing a minimum of 32 ETH will hold the NFT, which represents the economic interest in the validator.

ether.fi Completes USD 5.3 Million Funding Round Co-led by NIV and Chapter One, Launches Liquid Staking Platform

Retrieved on: 
Wednesday, March 1, 2023
DSRV, Decentralized finance, USS Thomaston (LSD-28), Ecosystem, Chapter One, Maelstrom, ETH, NIV, Risk, Web3, NFT, Capital, DVT, Distribution, LSD, Version One Ventures, Treasury, Virtus Investment Partners, Kiln, Cryptocurrency, Ethereum

LONDON, March 1, 2023 /PRNewswire/ -- ether.fi, a liquid staking protocol designed with decentralization at its core, announced today that it has completed a USD$5.3m funding round co-led by investors North Island Ventures (NIV,) Chapter One, and Node Capital, with participation from Arrington Capital, Maelstrom, Version One Ventures and Purpose Investments.

Key Points: 
  • Node Capital, Arrington Capital, Maelstrom, Version One Ventures, and Purpose Investments also back staking protocol to address issues of centralized staking markets.
  • As a decentralized non-custodial staking solution, ether.fi allows stakers to retain control of their keys while delegating validator operations to a node operator.
  • ether.fi brings a new platform approach to the staking market.
  • Ethereum stakers depositing a minimum of 32 ETH will hold the NFT, which represents the economic interest in the validator.